NEWS RELEASE

Department of Defense
United States Army Medical Research and Development Command
Congressionally Directed Medical Research Programs

Released: March 25, 2024

Fiscal Year 2024 CDMRP Research Funding

FORT DETRICK, Md. - On March 23, 2024, the President signed into law the "Further Consolidated Appropriations Act, 2024," which includes funding for the medical research programs managed by the Congressionally Directed Medical Research Programs.

• Alcohol and Substance Use Disorders Research Program - $4.0 million
• Amyotrophic Lateral Sclerosis Research Program - $40.0 million
• Arthritis Research Program - $10.0 million (new for FY24)
• Autism Research Program - $15.0 million
• Bone Marrow Failure Disease Research Program - $7.5 million
• Breast Cancer Research Program - $150.0 million
• Combat Readiness Medical Research Program - $5.0 million
• Duchenne Muscular Dystrophy Research Program - $10.0 million
• Epilepsy Research Program - $12.0 million
• Glioblastoma Research Program - $10.0 million (new for FY24)
• Hearing Restoration Research Program - $5.0 million
• Joint Warfighter Medical Research Program - $20.0 million
• Kidney Cancer Research Program - $50.0 million
• Lung Cancer Research Program - $25.0 million
• Lupus Research Program - $10.0 million
• Melanoma Research Program - $40.0 million
• Military Burn Research Program - $10.0 million
• Multiple Sclerosis Research Program - $20.0 million
• Neurofibromatosis Research Program - $25.0 million
• Ovarian Cancer Research Program - $45.0 million
• Pancreatic Cancer Research Program - $15.0 million
• Parkinson's Research Program - $16.0 million
• Peer Reviewed Alzheimer's Research Program - $15.0 million
• Peer Reviewed Cancer Research Program (18 topics) - $130.0 million
• Peer Reviewed Medical Research Program (42 topics) - $370.0 million
• Peer Reviewed Orthopaedic Research Program - $30.0 million
• Prostate Cancer Research Program - $110 million
• Rare Cancers Research Program - $17.5 million
• Reconstructive Transplant Research Program - $12.0 million
• Spinal Cord Injury Research Program - $40.0 million
• Tick-Borne Disease Research Program - $7.0 million
• Toxic Exposures Research Program - $30.0 million
• Traumatic Brain Injury and Psychological Health Research Program - $175.0 million
• Tuberous Sclerosis Complex Research Program - $8.0 million
• Vision Research Program - $20.0 million

Funding opportunity announcements are forthcoming. These announcements will include detailed descriptions of funding mechanisms, evaluation criteria, submission requirements, and deadlines.

When released, each funding opportunity announcement will be available at CDMRP https://cdmrp.health.mil, Grants.gov https://www.grants.gov/, or eBRAP https://ebrap.org/.

To learn more about the CDMRP, our research programs, previous awardees, and to read about funded research projects, please visit the website at https://cdmrp.health.mil.

Point of Contact:

Congressionally Directed Medical Research Programs Public Affairs
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@health.mil